Mayo Clinic Q and A: Rare, inherited risk factor can result in emphysema and liver damage
DEAR MAYO CLINIC:?A family friend was recently diagnosed with emphysema, but he never smoked and was told that his condition was caused by alpha-1. What is this, and how is it diagnosed? ANSWER: Emphysema?is one of a group of lung diseases, including chronic bronchitis, that make up chronic obstructive pulmonary disease, or COPD. Tobacco smoking [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 15, 2019 Category: Databases & Libraries Source Type: news

Ask How Do You Get Emphysema
How Do You Get Emphysema? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 14, 2019 Category: General Medicine Source Type: news

Daily Vitamin D Could Be a Lifesaver for Some COPD Patients
FRIDAY, Jan. 11, 2019 -- Deadly lung attacks may be averted in some COPD patients with a daily dose of vitamin D, new research suggests. Chronic obstructive pulmonary disease, or COPD, includes a number of lung conditions, including emphysema and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 11, 2019 Category: General Medicine Source Type: news

Penn Highlands Healthcare first in the region to offer first FDA-approved lung valve for patients with severe COPD/emphysema
(Pulmonx) Penn Highlands Healthcare is the first medical facility in the region to offer bronchoscopic lung volume reduction using the first lung valve approved by the US Food and Drug Administration for helping emphysema patients breathe easier without major surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news

Chronic obstructive pulmonary disease in over 16s diagnosis and management NICE guideline [NG115]
This guideline covers diagnosing and managing chronic obstructive pulmonary disease (COPD) in people aged 16 and older, which includes emphysema and chronic bronchitis. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer. It was published in December 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 20, 2018 Category: Consumer Health News Source Type: news

Olympus wins FDA nod for Spiration bronchial valve
Olympus (TYO:7733) said yesterday that it won FDA approval for its Spiration Valve System intended to treat severe emphysema, which was designated as a breakthrough medical device. The Spiration Valve is an umbrella shaped device intended to improve breathing by blocking airflow to diseased portions of the lung, the Tokyo-based company said. The device is placed during a bronchoscopic procedure to reduce lung volume in diseased lung sections and allow healthier tissue in the remaining portion of the lung to function better. Approval of the device came based on the results from the Emprove clinical trial of the SVS, which...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Olympus Source Type: news

Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
Minimally invasive therapy offers non-invasive patient screening with short procedure time and is shown to improve lung function and quality of life CENTER VALLEY, Pa., Dec. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technol... Devices, FDA Olympus Medical Systems, Spiration Valve, Emphysema, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2018 Category: Pharmaceuticals Source Type: news

Pulmonx wins Aetna coverage for Zephyr endobronchial valve
Pulmonx said yesterday that it won national coverage through health insurer Aetna for its Zephyr endobronchial valve system intended for treating severe emphysema and chronic obstructive pulmonary disorder. The coverage will make the Zephyr valve available to Aetna’s 22 million members, the Redwood City, Calif.-based company said. Under its new policy, Aetna specifically named the Zephyr as an approved bronchoscopic option for lung volume reduction, considering it medically necessary for the broncoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung with littl...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory Pulmonx Source Type: news

Banner University Medicine first in Arizona to offer new option for patients with severe COPD/emphysema
(Pulmonx) Banner University Medicine Lung Institute is the first in Arizona and second in the US to offer a new lung valve treatment for patients with severe COPD or emphysema. Recently approved by the FDA under their 'Breakthrough Devices' designation, the Zephyr ® Endobronchial Valve system is a major advancement in treatment because it is the first minimally invasive procedure to help emphysema sufferers breathe easier without major surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 12, 2018 Category: International Medicine & Public Health Source Type: news

Gala Therapeutics launches RheOx chronic bronchitis trial
Gala Therapeutics said today that it launched an early feasibility study of its RheOx system for treating chronic bronchitis, and that the first two patients in the trial have already been enrolled. Initial patient enrollment took place at the University of Pittsburgh Medical Center, with RheOx bronchial rheoplasty procedures performed by Dr. Frank Sciurba and Roy Semaan, the Menlo Park, Calif.-based company said. “We are pleased to partner with Gala in treating the first US patients and thus continuing the contribution of UPMC as a leader in the development of novel devices for our patients with COPD. RheOx offers ...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory galatherapeutics Source Type: news

ANI Announces Launch of Authorized Generic of Brethine(R)
BAUDETTE, Minn., Oct. 16, 2018 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Terbutaline Sulfate Tablets USP, 2.5mg and 5mg, an authorized generic of Brethine®. Th... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Terbutaline, Brethine, bronchitis, emphysema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2018 Category: Pharmaceuticals Source Type: news

Smoking Seems to Weaken the Immune System: Study
TUESDAY, Oct. 2, 2018 -- The list of health risks linked to smoking continues to grow. A small study reports that, aside from lung cancer, emphysema and heart disease, cigarette smokers also have weakened immune systems affecting their dental... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 2, 2018 Category: General Medicine Source Type: news

A New Definition for Emphysema A New Definition for Emphysema
A new study has identified a clinically relevant definition for emphysema using CT imaging.Medscape Critical Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news

Zapping Airway Nerves May Help COPD Patients
COPD, which is often linked to smoking, is a progressive deterioration of lung function that involves a combination of bronchitis and emphysema symptoms. (Source: WebMD Health)
Source: WebMD Health - September 18, 2018 Category: Consumer Health News Source Type: news

New Bronchoscopic Option Used for Severe Emphysema
First bronchoscopic lung volume reduction using endobronchial valve performed at Temple University (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 10, 2018 Category: Respiratory Medicine Tags: Pulmonology, Surgery, Institutional, Source Type: news